Literature DB >> 19016446

Activation of murine macrophages.

David M Mosser1, Xia Zhang.   

Abstract

Our understanding of cell mediated immunity (CMI) has revealed the importance of activated macrophages as key immune effector cells. Over the past decade, we have come to realize that macrophages exhibit remarkable plasticity, and different populations of macrophages with distinct physiologies can develop in response to different stimuli. In fact, it is likely that the number of different macrophage populations that can arise may be as diverse as the activating stimuli that induce them. Some of these stimuli can instruct macrophages to kill microbes (classical activation), lay down extracellular matrix components to promote wound healing (alternative activation), or secrete anti-inflammatory cytokines to terminate inflammation (regulatory macrophages). New ways to biochemically identify these cells have led to a better understanding of the heterogeneity of activated macrophages. As our understanding of the various macrophage populations increases, so does the potential for therapeutic intervention based on targeting specific populations of activated macrophages. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016446      PMCID: PMC2822273          DOI: 10.1002/0471142735.im1402s83

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  15 in total

1.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 2.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 3.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

Review 4.  Activation of mononuclear phagocytes: fact, fancy, and future.

Authors:  Z A Cohn
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

5.  Macrophage activation revisited.

Authors:  A Celada; C Nathan
Journal:  Immunol Today       Date:  1994-03

6.  Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages.

Authors:  Geert Raes; Patrick De Baetselier; Wim Noël; Alain Beschin; Frank Brombacher; Gholamreza Hassanzadeh Gh
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

Review 7.  IL-13 effector functions.

Authors:  Thomas A Wynn
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 8.  Cancer related inflammation: the macrophage connection.

Authors:  Antonio Sica; Paola Allavena; Alberto Mantovani
Journal:  Cancer Lett       Date:  2008-04-29       Impact factor: 8.679

9.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.

Authors:  M Stein; S Keshav; N Harris; S Gordon
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  75 in total

1.  Macrophages participate in IL-17-mediated inflammation.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; Sufey Ong; Farhan Quader; Ping Chen; Dongfeng Zheng; Patrizio Caturegli; Noel R Rose; Daniela Ciháková
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

2.  Strategies for functional bioscaffold-based skeletal muscle reconstruction.

Authors:  Brian M Sicari; Jenna L Dziki; Stephen F Badylak
Journal:  Ann Transl Med       Date:  2015-10

3.  Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery.

Authors:  Erica B Peters; Nick D Tsihlis; Mark R Karver; Stacey M Chin; Bruno Musetti; Benjamin T Ledford; Edward M Bahnson; Samuel I Stupp; Melina R Kibbe
Journal:  Adv Healthc Mater       Date:  2019-01-08       Impact factor: 9.933

4.  Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.

Authors:  Laura Campbell; Elaine Emmerson; Helen Williams; Charis R Saville; Andrée Krust; Pierre Chambon; Kimberly A Mace; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

5.  The activating effect of IFN-γ on monocytes/macrophages is regulated by the LIF-trophoblast-IL-10 axis via Stat1 inhibition and Stat3 activation.

Authors:  Angham Dallagi; Julie Girouard; Jovane Hamelin-Morrissette; Rachel Dadzie; Laetitia Laurent; Cathy Vaillancourt; Julie Lafond; Christian Carrier; Carlos Reyes-Moreno
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

6.  Improved segmented-scan spectral stitching for stable isotope resolved metabolomics (SIRM) by ultra-high-resolution Fourier transform mass spectrometry.

Authors:  Woo-Young Kang; Patrick T Thompson; Salim S El-Amouri; Teresa W M Fan; Andrew N Lane; Richard M Higashi
Journal:  Anal Chim Acta       Date:  2019-06-11       Impact factor: 6.558

7.  A Three-Dimensional Chondrocyte-Macrophage Coculture System to Probe Inflammation in Experimental Osteoarthritis.

Authors:  Satyavrata Samavedi; Patricia Diaz-Rodriguez; Joshua D Erndt-Marino; Mariah S Hahn
Journal:  Tissue Eng Part A       Date:  2016-11-18       Impact factor: 3.845

8.  Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Amanda Roloson; Monica Ilies; Charles Perkins; William O'Brien; Stephen Cederbaum; David W Christianson; Nives Zimmermann; Marc E Rothenberg; Fred D Finkelman
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

9.  Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.

Authors:  Amankeldi A Salybekov; Akira T Kawaguchi; Haruchika Masuda; Kosit Vorateera; Chisa Okada; Takayuki Asahara
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

10.  The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.

Authors:  Z S Guo; V Parimi; M E O'Malley; P Thirunavukarasu; M Sathaiah; F Austin; D L Bartlett
Journal:  Gene Ther       Date:  2010-08-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.